Skip to content
ClinCalc Pro
Menu
Vasopressin Analogue V2 (Antidiuretic/Haemostatic)

Desmopressin (Surgical — Haemostasis/Platelet Dysfunction)

Brand names: DDAVP, Desmopressin Acetate, Octim (intranasal)

Desmopressin is a synthetic vasopressin analogue used in the surgical setting to improve haemostasis in mild haemophilia A, von Willebrand disease and certain platelet dysfunctions, including uraemic and antiplatelet-related bleeding.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It releases stored von Willebrand factor and factor VIII from endothelium and enhances platelet adhesion, transiently improving primary haemostasis.

Prescribing in practice

  • It has an antidiuretic effect and can cause dilutional hyponatraemia and seizures, so restrict fluid intake and monitor sodium, with particular caution in young children and the elderly.
  • Tachyphylaxis occurs with repeated dosing as factor stores deplete, limiting its usefulness for prolonged bleeding.
  • Use cautiously in cardiovascular disease because of fluid retention and rare thrombotic events, and avoid in type 2B von Willebrand disease.

Monitoring

Monitor serum sodium, fluid balance, blood pressure and the haemostatic response when used to cover surgery or bleeding.

Counselling the patient

  • Limit how much you drink for the period advised after the dose to protect your salt levels.
  • Report headache, nausea, confusion or drowsiness promptly.

Evidence & guidelines

Its haemostatic use is established in haemophilia and von Willebrand disease management guidelines and supported by long-standing clinical use.

Reference: UKHCDO Guidelines on vWD Management 2014; MHRA Drug Safety Update (desmopressin hyponatraemia); BCSH Guidelines on Perioperative Management of Anticoagulation and Antiplatelet Therapy 2016; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.